Geode Capital Management LLC Decreases Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Geode Capital Management LLC decreased its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 1.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,547,828 shares of the medical instruments supplier’s stock after selling 67,567 shares during the period. Geode Capital Management LLC owned about 1.78% of DENTSPLY SIRONA worth $96,028,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. M&T Bank Corp increased its position in shares of DENTSPLY SIRONA by 5.6% during the third quarter. M&T Bank Corp now owns 39,079 shares of the medical instruments supplier’s stock worth $1,058,000 after acquiring an additional 2,062 shares during the last quarter. Barclays PLC increased its holdings in DENTSPLY SIRONA by 21.8% during the 3rd quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier’s stock worth $8,301,000 after purchasing an additional 54,920 shares during the last quarter. Y Intercept Hong Kong Ltd raised its position in shares of DENTSPLY SIRONA by 28.8% in the 3rd quarter. Y Intercept Hong Kong Ltd now owns 30,823 shares of the medical instruments supplier’s stock valued at $834,000 after purchasing an additional 6,899 shares in the last quarter. MML Investors Services LLC boosted its stake in shares of DENTSPLY SIRONA by 2.1% during the 3rd quarter. MML Investors Services LLC now owns 29,682 shares of the medical instruments supplier’s stock valued at $803,000 after buying an additional 620 shares during the last quarter. Finally, iSAM Funds UK Ltd acquired a new stake in shares of DENTSPLY SIRONA during the third quarter worth approximately $394,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ XRAY opened at $18.68 on Thursday. DENTSPLY SIRONA Inc. has a 1-year low of $17.21 and a 1-year high of $37.60. The firm has a market capitalization of $3.71 billion, a PE ratio of -9.02, a P/E/G ratio of 1.93 and a beta of 0.96. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The business’s fifty day moving average price is $21.07 and its two-hundred day moving average price is $24.04.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.02. The firm had revenue of $951.00 million for the quarter, compared to the consensus estimate of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. DENTSPLY SIRONA’s quarterly revenue was up .4% compared to the same quarter last year. During the same period last year, the firm posted $0.49 EPS. On average, research analysts expect that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 10th. Stockholders of record on Friday, December 27th will be given a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, December 27th. This represents a $0.64 annualized dividend and a dividend yield of 3.43%. DENTSPLY SIRONA’s dividend payout ratio is presently -30.92%.

Analysts Set New Price Targets

Several research firms recently issued reports on XRAY. Robert W. Baird cut their price target on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a report on Friday, November 8th. Leerink Partners cut shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. UBS Group lowered their price objective on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a report on Tuesday, December 3rd. Barrington Research reduced their target price on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a report on Friday, November 8th. Finally, Mizuho initiated coverage on DENTSPLY SIRONA in a report on Wednesday, December 4th. They issued a “neutral” rating and a $21.00 price target for the company. Eight analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $27.91.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.